[Assessment of the treatment of glucocorticoid-induced osteoporosis].

Shogo Asano, Atsushi Suzuki

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Glucocorticoid-induced osteoporosis (GIOP) is known as a serious adverse side effect during long-term glucocorticoid treatment. Several clinical guidelines are available to whom and how we should start to treat GIOP. However, the assessment of the treatment of GIOP is still controversial. Accumulating evidences suggest us that both bone mineral density and bone turn over markers could reflect the effect of some pharmacological agents on bone metabolism. However, further studies would be required for precise assessment of the efficacy of drugs on fracture prevention in GIOP.

Original languageEnglish
Pages (from-to)401-408
Number of pages8
JournalUnknown Journal
Volume23
Issue number3
Publication statusPublished - 01-01-2013

Fingerprint

Glucocorticoids
Osteoporosis
Bone and Bones
Bone Density
Pharmacology
Guidelines
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{3db76f99e3df4bf5a551636f3b06d129,
title = "[Assessment of the treatment of glucocorticoid-induced osteoporosis].",
abstract = "Glucocorticoid-induced osteoporosis (GIOP) is known as a serious adverse side effect during long-term glucocorticoid treatment. Several clinical guidelines are available to whom and how we should start to treat GIOP. However, the assessment of the treatment of GIOP is still controversial. Accumulating evidences suggest us that both bone mineral density and bone turn over markers could reflect the effect of some pharmacological agents on bone metabolism. However, further studies would be required for precise assessment of the efficacy of drugs on fracture prevention in GIOP.",
author = "Shogo Asano and Atsushi Suzuki",
year = "2013",
month = "1",
day = "1",
language = "English",
volume = "23",
pages = "401--408",
journal = "Unknown Journal",
number = "3",

}

[Assessment of the treatment of glucocorticoid-induced osteoporosis]. / Asano, Shogo; Suzuki, Atsushi.

In: Unknown Journal, Vol. 23, No. 3, 01.01.2013, p. 401-408.

Research output: Contribution to journalReview article

TY - JOUR

T1 - [Assessment of the treatment of glucocorticoid-induced osteoporosis].

AU - Asano, Shogo

AU - Suzuki, Atsushi

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Glucocorticoid-induced osteoporosis (GIOP) is known as a serious adverse side effect during long-term glucocorticoid treatment. Several clinical guidelines are available to whom and how we should start to treat GIOP. However, the assessment of the treatment of GIOP is still controversial. Accumulating evidences suggest us that both bone mineral density and bone turn over markers could reflect the effect of some pharmacological agents on bone metabolism. However, further studies would be required for precise assessment of the efficacy of drugs on fracture prevention in GIOP.

AB - Glucocorticoid-induced osteoporosis (GIOP) is known as a serious adverse side effect during long-term glucocorticoid treatment. Several clinical guidelines are available to whom and how we should start to treat GIOP. However, the assessment of the treatment of GIOP is still controversial. Accumulating evidences suggest us that both bone mineral density and bone turn over markers could reflect the effect of some pharmacological agents on bone metabolism. However, further studies would be required for precise assessment of the efficacy of drugs on fracture prevention in GIOP.

UR - http://www.scopus.com/inward/record.url?scp=84883895288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883895288&partnerID=8YFLogxK

M3 - Review article

VL - 23

SP - 401

EP - 408

JO - Unknown Journal

JF - Unknown Journal

IS - 3

ER -